Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Allopregnanolone in PTSD - Pharmacokinetic Studies
NCT04468360Phase 2Terminated
- Sponsor
- Boston University
- Start
- Mar 2022
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of brexanolone in post-traumatic stress disorder (PTSD), sponsored by Boston University. Started Mar 2022; status: terminated.
02
Drugs
brexanolone
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT04468360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04468360.